{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:43:44Z","timestamp":1773287024621,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T00:00:00Z","timestamp":1503014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T00:00:00Z","timestamp":1503014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Conventional disease animal models have limitations on the conformity to the actual clinical situation. Disease-syndrome combination (DS) modeling may provide a more efficient strategy for biomedicine research. Disease model and DS model of renal fibrosis in chronic kidney disease were established by ligating the left ureter and by ligating unilateral ureteral combined with exhaustive swimming, respectively. Serum metabolomics was conducted to evaluate disease model and DS model by using ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Potential endogenous biomarkers were identified by multivariate statistical analysis. There are no differences between two models regarding their clinical biochemistry and kidney histopathology, while metabolomics highlights their difference. It is found that abnormal sphingolipid metabolism is a common characteristic of both models, while arachidonic acid metabolism, linolenic acid metabolism and glycerophospholipid metabolism are highlighted in DS model. Metabolomics is a promising approach to evaluate experiment animal models. DS model are comparatively in more coincidence with clinical settings, and is superior to single disease model for the biomedicine research.<\/jats:p>","DOI":"10.1038\/s41598-017-09311-0","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T15:01:23Z","timestamp":1502722883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1170-4591","authenticated-orcid":false,"given":"Shasha","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nizhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,18]]},"reference":[{"key":"9311_CR1","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/nm.2224","volume":"16","author":"M Jucker","year":"2010","unstructured":"Jucker, M. The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nature medicine \n                           16, 1210\u20131214, doi:10.1038\/nm.2224 (2010).","journal-title":"Nature medicine"},{"key":"9311_CR2","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3892\/mmr.2014.2323","volume":"10","author":"GT Jiang","year":"2014","unstructured":"Jiang, G. T., Chen, X., Li, D., An, H. X. & Jiao, J. D. Ulinastatin attenuates renal interstitial inflammation and inhibits fibrosis progression in rats under unilateral ureteral obstruction. Molecular medicine reports \n                           10, 1501\u20131508, doi:10.3892\/mmr.2014.2323 (2014).","journal-title":"Molecular medicine reports"},{"key":"9311_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1136\/bmj.39048.407928.BE","volume":"334","author":"P Perel","year":"2007","unstructured":"Perel, P. et al. Comparison of treatment effects between animal experiments and clinical trials: systematic review. Brit Med J \n                           334, 197\u2013200, doi:10.1136\/bmj.39048.407928.BE (2007).","journal-title":"Brit Med J"},{"key":"9311_CR4","doi-asserted-by":"publisher","unstructured":"Wang, H. Z., Liu, X., Lv, B., Yang, F. & Hong, Y. Z. Reliable Multi-Label Learning via Conformal Predictor and Random Forest for Syndrome Differentiation of Chronic Fatigue in Traditional Chinese Medicine. Plos One \n                           9, doi:10.1371\/journal.pone.0099565 (2014).","DOI":"10.1371\/journal.pone.0099565"},{"key":"9311_CR5","doi-asserted-by":"publisher","unstructured":"Wang, J. & Xiong, X. J. Current Situation and Perspectives of Clinical Study in Integrative Medicine in China. Evid-Based Compl Alt, doi:10.1155\/2012\/268542 (2012).","DOI":"10.1155\/2012\/268542"},{"key":"9311_CR6","first-page":"12","volume":"10","author":"LP Liu","year":"2006","unstructured":"Liu, L. P. Differences in biochemical indexes of blood and relevant factors of obesity in hypertensive patients with different syndromes of traditional Chinese medicine. Chinese Journal of Clinical Rehabilitation \n                           10, 12\u201313 (2006).","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"key":"9311_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cbi.2016.03.028","volume":"252","author":"DQ Chen","year":"2016","unstructured":"Chen, D. Q. et al. Metabolomic application in toxicity evaluation and toxicological biomarker identification of natural product. Chem Biol Interact \n                           252, 114\u2013130, doi:10.1016\/j.cbi.2016.03.028 (2016).","journal-title":"Chem Biol Interact"},{"key":"9311_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cbi.2017.06.011","volume":"273","author":"M Wang","year":"2017","unstructured":"Wang, M. et al. Metabolomics highlights pharmacological bioactivity and biochemical mechanism of traditional Chinese medicine. Chem Biol Interact \n                           273, 133\u2013141, doi:10.1016\/j.cbi.2017.06.011 (2017).","journal-title":"Chem Biol Interact"},{"key":"9311_CR9","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0140-6736(15)00013-6","volume":"386","author":"J Bates","year":"2015","unstructured":"Bates, J., Chitani, A. & Dreyer, G. Caring for patients with end-stage kidney disease. Lancet \n                           386, 854\u2013855 (2015).","journal-title":"Lancet"},{"key":"9311_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cbi.2017.05.025","volume":"273","author":"L Chen","year":"2017","unstructured":"Chen, L. et al. Role of RAS\/Wnt\/beta-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy. Chem Biol Interact \n                           273, 56\u201372, doi:10.1016\/j.cbi.2017.05.025 (2017).","journal-title":"Chem Biol Interact"},{"key":"9311_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.tvjl.2014.10.009","volume":"203","author":"J Lawson","year":"2015","unstructured":"Lawson, J., Elliott, J., Wheeler-Jones, C., Syme, H. & Jepson, R. Renal fibrosis in feline chronic kidney disease: Known mediators and mechanisms of injury. Vet J \n                           203, 18\u201326, doi:10.1016\/j.tvjl.2014.10.009 (2015).","journal-title":"Vet J"},{"key":"9311_CR12","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/ndt\/gft217","volume":"28","author":"ON Goek","year":"2013","unstructured":"Goek, O. N. et al. Metabolites associate with kidney function decline and incident chronic kidney disease in the general population. Nephrol Dial Transpl \n                           28, 2131\u20132138, doi:10.1093\/ndt\/gft217 (2013).","journal-title":"Nephrol Dial Transpl"},{"key":"9311_CR13","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1681\/ASN.2012101006","volume":"24","author":"EP Rhee","year":"2013","unstructured":"Rhee, E. P. et al. A Combined Epidemiologic and Metabolomic Approach Improves CKD Prediction. J Am Soc Nephrol \n                           24, 1330\u20131338, doi:10.1681\/Asn.2012101006 (2013).","journal-title":"J Am Soc Nephrol"},{"key":"9311_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cca.2013.03.033","volume":"422","author":"YY Zhao","year":"2013","unstructured":"Zhao, Y. Y. Metabolomics in chronic kidney disease. Clin Chim Acta \n                           422, 59\u201369, doi:10.1016\/j.cca.2013.03.033 (2013).","journal-title":"Clin Chim Acta"},{"key":"9311_CR15","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1021\/acs.jproteome.6b00583","volume":"15","author":"ZH Zhang","year":"2016","unstructured":"Zhang, Z. H. et al. Metabolomic Signatures of Chronic Kidney Disease of Diverse Etiologies in the Rats and Humans. J Proteome Res \n                           15, 3802\u20133812, doi:10.1021\/acs.jproteome.6b00583 (2016).","journal-title":"J Proteome Res"},{"key":"9311_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrneph.2017.30","volume":"13","author":"B Hocher","year":"2017","unstructured":"Hocher, B. & Adamski, J. Metabolomics for clinical use and research in chronic kidney disease. Nat Rev Nephrol \n                           13, 269\u2013284, doi:10.1038\/nrneph.2017.30 (2017).","journal-title":"Nat Rev Nephrol"},{"key":"9311_CR17","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3109\/1354750X.2012.724450","volume":"17","author":"YY Zhao","year":"2012","unstructured":"Zhao, Y. Y., Cheng, X. L., Wei, F., Bai, X. & Lin, R. C. Application of faecal metabonomics on an experimental model of tubulointerstitial fibrosis by ultra performance liquid chromatography\/high-sensitivity mass spectrometry with MSE data collection technique. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals \n                           17, 721\u2013729, doi:10.3109\/1354750X.2012.724450 (2012).","journal-title":"Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals"},{"key":"9311_CR18","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1016\/j.procbio.2012.07.008","volume":"47","author":"YY Zhao","year":"2012","unstructured":"Zhao, Y. Y. et al. Urinary metabonomics study on the protective effects of ergosta-4, 6, 8(14), 22-tetraen-3-one on chronic renal failure in rats using UPLC Q-TOF\/MS and a novel MSE data collection technique. Process Biochem \n                           47, 1980\u20131987, doi:10.1016\/j.procbio.2012.07.008 (2012).","journal-title":"Process Biochem"},{"key":"9311_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jpba.2013.03.028","volume":"81-82","author":"YY Zhao","year":"2013","unstructured":"Zhao, Y. Y., Lei, P., Chen, D. Q., Feng, Y. L. & Bai, X. Renal metabolic profiling of early renal injury and renoprotective effects of Poria cocos epidermis using UPLC Q-TOF\/HSMS\/MSE. J Pharmaceut Biomed \n                           81\u201382, 202\u2013209, doi:10.1016\/j.jpba.2013.03.028 (2013).","journal-title":"J Pharmaceut Biomed"},{"key":"9311_CR20","doi-asserted-by":"publisher","first-page":"75612","DOI":"10.1039\/C5RA12710F","volume":"5","author":"JW Fang","year":"2015","unstructured":"Fang, J. W. et al. A urine metabonomics study of chronic renal failure and intervention effects of total aglycone extracts of Scutellaria baicalensis in 5\/6 nephrectomy rats. Rsc Adv \n                           5, 75612\u201375621, doi:10.1039\/c5ra12710f (2015).","journal-title":"Rsc Adv"},{"key":"9311_CR21","doi-asserted-by":"publisher","unstructured":"Zhang, Z. H. et al. Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis. Sci Rep-Uk \n                           5, doi: 10.1038\/Srep14472 (2015).","DOI":"10.1038\/Srep14472"},{"key":"9311_CR22","doi-asserted-by":"publisher","unstructured":"Zhao, Y. Y. et al. Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis, and Nrf2 dysfunction in aristolochic acid-induced nephropathy. Sci Rep-Uk 5, doi: 10.1038\/Srep12936 (2015).","DOI":"10.1038\/Srep12936"},{"key":"9311_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jpba.2016.02.035","volume":"124","author":"YH Li","year":"2016","unstructured":"Li, Y. H., Tan, Y. F., Cai, H. D. & Zhang, J. Q. Metabonomic study of the fruits of Alpinia oxyphylla as an effective treatment for chronic renal injury in rats. J Pharmaceut Biomed \n                           124, 236\u2013245, doi:10.1016\/j.jpba.2016.02.035 (2016).","journal-title":"J Pharmaceut Biomed"},{"key":"9311_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2217\/bmm.14.81","volume":"9","author":"YY Zhao","year":"2015","unstructured":"Zhao, Y. Y., Cheng, X. L., Lin, R. C. & Wei, F. Lipidomics applications for disease biomarker discovery in mammal models. Biomarkers in medicine \n                           9, 153\u2013168, doi:10.2217\/bmm.14.81 (2015).","journal-title":"Biomarkers in medicine"},{"key":"9311_CR25","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3736\/jcim20101206","volume":"8","author":"K Qu","year":"2010","unstructured":"Qu, K. et al. [Common syndrome factors of traditional Chinese medicine in chronic renal failure based on the questionnaire investigation among experts]. Zhong xi yi jie he xue bao\u2009=\u2009Journal of Chinese integrative medicine \n                           8, 1147\u20131152 (2010).","journal-title":"Zhong xi yi jie he xue bao\u2009=\u2009Journal of Chinese integrative medicine"},{"key":"9311_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cbi.2014.02.014","volume":"215","author":"YY Zhao","year":"2014","unstructured":"Zhao, Y. Y. & Lin, R. C. UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics. Chem Biol Interact \n                           215, 7\u201316, doi:10.1016\/j.cbi.2014.02.014 (2014).","journal-title":"Chem Biol Interact"},{"key":"9311_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cbi.2015.01.023","volume":"228","author":"H Miao","year":"2015","unstructured":"Miao, H. et al. Plasma lipidomics reveal profound perturbation of glycerophospholipids, fatty acids, and sphingolipids in diet-induced hyperlipidemia. Chem-Biol Interact \n                           228, 79\u201387, doi:10.1016\/j.cbi.2015.01.023 (2015).","journal-title":"Chem-Biol Interact"},{"key":"9311_CR28","doi-asserted-by":"publisher","first-page":"64208","DOI":"10.1039\/C5RA09766E","volume":"5","author":"H Miao","year":"2015","unstructured":"Miao, H. et al. The antihyperlipidemic effect of Fu-Ling-Pi is associated with abnormal fatty acid metabolism as assessed by UPLC-HDMS-based lipidomics. Rsc Adv \n                           5, 64208\u201364219, doi:10.1039\/c5ra09766e (2015).","journal-title":"Rsc Adv"},{"key":"9311_CR29","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1021\/acs.jafc.5b05350","volume":"64","author":"H Miao","year":"2016","unstructured":"Miao, H. et al. Lipidomics Biomarkers of Diet-Induced Hyperlipidemia and Its Treatment with Poria cocos. Journal of agricultural and food chemistry \n                           64, 969\u2013979, doi:10.1021\/acs.jafc.5b05350 (2016).","journal-title":"Journal of agricultural and food chemistry"},{"key":"9311_CR30","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.cca.2011.12.014","volume":"413","author":"YY Zhao","year":"2012","unstructured":"Zhao, Y. Y., Liu, J., Cheng, X. L., Bai, X. & Lin, R. C. Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF\/MS. Clin Chim Acta \n                           413, 642\u2013649, doi:10.1016\/j.cca.2011.12.014 (2012).","journal-title":"Clin Chim Acta"},{"key":"9311_CR31","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1021\/pr3007792","volume":"12","author":"YY Zhao","year":"2013","unstructured":"Zhao, Y. Y. et al. Intrarenal Metabolomic Investigation of Chronic Kidney Disease and its TGF-beta 1 Mechanism in Induced-adenine Rats using UPLC Q-TOF\/HSMS\/MSE. J Proteome Res \n                           12, 692\u2013703, doi:10.1021\/pr3007792 (2013).","journal-title":"J Proteome Res"},{"key":"9311_CR32","doi-asserted-by":"publisher","first-page":"W251","DOI":"10.1093\/nar\/gkv380","volume":"43","author":"J Xia","year":"2015","unstructured":"Xia, J., Sinelnikov, I. V., Han, B. & Wishart, D. S. MetaboAnalyst 3.0\u2013making metabolomics more meaningful. Nucleic acids research \n                           43, W251\u2013257, doi:10.1093\/nar\/gkv380 (2015).","journal-title":"Nucleic acids research"},{"key":"9311_CR33","doi-asserted-by":"publisher","unstructured":"Xia, J. & Wishart, D. S. Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis. Current protocols in bioinformatics 55, 14 10 11\u201314 10 91, doi:10.1002\/cpbi.11 (2016).","DOI":"10.1002\/cpbi.11"},{"key":"9311_CR34","doi-asserted-by":"publisher","unstructured":"Chen, D. Q. et al. The link between phenotype and fatty acid metabolism in advanced chronic kidney disease. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, doi:10.1093\/ndt\/gfw415 (2017).","DOI":"10.1093\/ndt\/gfw415"},{"key":"9311_CR35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.redox.2017.03.017","volume":"12","author":"DQ Chen","year":"2017","unstructured":"Chen, D. Q. et al. Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt\/beta-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease. Redox Biol \n                           12, 505\u2013521, doi:10.1016\/j.redox.2017.03.017 (2017).","journal-title":"Redox Biol"},{"key":"9311_CR36","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1007\/s00216-016-9368-4","volume":"408","author":"Z Xiang","year":"2016","unstructured":"Xiang, Z., Sun, H., Cai, X. & Chen, D. The study on serum and urine of renal interstitial fibrosis rats induced by unilateral ureteral obstruction based on metabonomics and network analysis methods. Anal Bioanal Chem \n                           408, 2607\u20132619, doi:10.1007\/s00216-016-9368-4 (2016).","journal-title":"Anal Bioanal Chem"},{"key":"9311_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.clinbiochem.2014.07.019","volume":"47","author":"YY Zhao","year":"2014","unstructured":"Zhao, Y. Y., Cheng, X. L., Vaziri, N. D., Liu, S. & Lin, R. C. UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry. Clinical biochemistry \n                           47, 16\u201326, doi:10.1016\/j.clinbiochem.2014.07.019 (2014).","journal-title":"Clinical biochemistry"},{"key":"9311_CR38","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1021\/acs.jproteome.6b00956","volume":"16","author":"H Chen","year":"2017","unstructured":"Chen, H. et al. Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism. J Proteome Res \n                           16, 1566\u20131578, doi:10.1021\/acs.jproteome.6b00956 (2017).","journal-title":"J Proteome Res"},{"key":"9311_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cbi.2014.06.029","volume":"220","author":"YY Zhao","year":"2014","unstructured":"Zhao, Y. Y., Wu, S. P., Liu, S. M., Zhang, Y. M. & Lin, R. C. Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications. Chem-Biol Interact \n                           220, 181\u2013192, doi:10.1016\/j.cbi.2014.06.029 (2014).","journal-title":"Chem-Biol Interact"},{"key":"9311_CR40","doi-asserted-by":"publisher","unstructured":"Zhao, Y. Y. et al. A Pharmaco-Metabonomic Study on Chronic Kidney Disease and Therapeutic Effect of Ergone by UPLC-QTOF\/HDMS. Plos One \n                           9, doi: 10.1371\/journal.pone.0115467 (2014).","DOI":"10.1371\/journal.pone.0115467"},{"key":"9311_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/908907","volume":"2013","author":"K Kurek","year":"2013","unstructured":"Kurek, K. et al. Metabolism, physiological role, and clinical implications of sphingolipids in gastrointestinal tract. BioMed research international \n                           2013, 908907, doi:10.1155\/2013\/908907 (2013).","journal-title":"BioMed research international"},{"key":"9311_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2119\/2006-00001.Kim","volume":"12","author":"S Kim","year":"2006","unstructured":"Kim, S. et al. Phytosphingosine stimulates the differentiation of human keratinocytes and inhibits TPA-induced inflammatory epidermal hyperplasia in hairless mouse skin. Mol Med \n                           12, 17\u201324, doi:10.2119\/2006-00001.Kim (2006).","journal-title":"Mol Med"},{"key":"9311_CR43","doi-asserted-by":"publisher","first-page":"F1032","DOI":"10.1152\/ajprenal.00152.2007","volume":"294","author":"X Ruan","year":"2008","unstructured":"Ruan, X., Zheng, F. & Guan, Y. PPARs and the kidney in metabolic syndrome. American journal of physiology. Renal physiology \n                           294, F1032\u20131047, doi:10.1152\/ajprenal.00152.2007 (2008).","journal-title":"American journal of physiology. Renal physiology"},{"key":"9311_CR44","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.cca.2010.02.063","volume":"411","author":"H Ikeda","year":"2010","unstructured":"Ikeda, H. et al. Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C. Clin Chim Acta \n                           411, 765\u2013770, doi:10.1016\/j.cca.2010.02.063 (2010).","journal-title":"Clin Chim Acta"},{"key":"9311_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbalip.2012.07.022","volume":"1831","author":"S Schwalm","year":"2013","unstructured":"Schwalm, S., Pfeilschifter, J. & Huwiler, A. Sphingosine-1-phosphate: a Janus-faced mediator of fibrotic diseases. Biochimica et biophysica acta \n                           1831, 239\u2013250, doi:10.1016\/j.bbalip.2012.07.022 (2013).","journal-title":"Biochimica et biophysica acta"},{"key":"9311_CR46","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.molmed.2008.08.005","volume":"14","author":"H Harizi","year":"2008","unstructured":"Harizi, H., Corcuff, J. B. & Gualde, N. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol Med \n                           14, 461\u2013469, doi:10.1016\/j.molmed.2008.08.005 (2008).","journal-title":"Trends Mol Med"},{"key":"9311_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/cbf.1012","volume":"21","author":"C Pompeia","year":"2003","unstructured":"Pompeia, C., Lima, T. & Curi, R. Arachidonic acid cytotoxicity: can arachidonic acid be a physiological mediator of cell death? Cell Biochem Funct \n                           21, 97\u2013104, doi:10.1002\/cbf.1012 (2003).","journal-title":"Cell Biochem Funct"},{"key":"9311_CR48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/1389200033336892","volume":"4","author":"X Zhao","year":"2003","unstructured":"Zhao, X. & Imig, J. D. Kidney CYP450 enzymes: Biological actions beyond drug metabolism. Curr Drug Metab \n                           4, 73\u201384, doi:10.2174\/1389200033336892 (2003).","journal-title":"Curr Drug Metab"},{"key":"9311_CR49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1665-2681(19)31810-1","volume":"8","author":"S El-Swefy","year":"2009","unstructured":"El-Swefy, S. & Hassanen, S. I. Improvement of hepatic fibrosis by leukotriene inhibition in cholestatic rats. Annals of hepatology \n                           8, 41\u201349 (2009).","journal-title":"Annals of hepatology"},{"key":"9311_CR50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1254\/fpj.123.15","volume":"123","author":"H Hirai","year":"2004","unstructured":"Hirai, H. [Prostaglandin D2 in allergy: PGD2 has dual receptor systems]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica \n                           123, 15\u201322 (2004).","journal-title":"Folia pharmacologica Japonica"},{"key":"9311_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0304-3835(02)00498-6","volume":"189","author":"H Pham","year":"2003","unstructured":"Pham, H., Banerjee, T., Nalbandian, G. M. & Ziboh, V. A. Activation of peroxisome proliferator-activated receptor (PPAR)-gamma by 15S-hydroxyeicosatrienoic acid parallels growth suppression of androgen-dependent prostatic adenocarcinoma cells. Cancer Lett \n                           189, 17\u201325, doi:10.1016\/S0304-3835(02)00498-6 (2003).","journal-title":"Cancer Lett"},{"key":"9311_CR52","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.plefa.2006.03.002","volume":"74","author":"JKA Hampel","year":"2006","unstructured":"Hampel, J. K. A. et al. Differential modulation of cell cycle, apoptosis and PPAR gamma 2 gene expression by PPAR gamma agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells. Prostag Leukotr Ess \n                           74, 283\u2013293, doi:10.1016\/j.plefa.2006.03.002 (2006).","journal-title":"Prostag Leukotr Ess"},{"key":"9311_CR53","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1017\/S0007114510005635","volume":"105","author":"J Meijerink","year":"2011","unstructured":"Meijerink, J. et al. The ethanolamide metabolite of DHA, docosahexaenoylethanolamine, shows immunomodulating effects in mouse peritoneal and RAW264.7 macrophages: evidence for a new link between fish oil and inflammation. The British journal of nutrition \n                           105, 1798\u20131807, doi:10.1017\/S0007114510005635 (2011).","journal-title":"The British journal of nutrition"},{"key":"9311_CR54","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jada.2008.12.022","volume":"109","author":"ND Riediger","year":"2009","unstructured":"Riediger, N. D., Othman, R. A., Suh, M. & Moghadasian, M. H. A Systemic Review of the Roles of n-3 Fatty Acids in Health and Disease. J Am Diet Assoc \n                           109, 668\u2013679, doi:10.1016\/j.jada.2008.12.022 (2009).","journal-title":"J Am Diet Assoc"},{"key":"9311_CR55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1365-277X.2007.00770.x","volume":"20","author":"CHS Ruxton","year":"2007","unstructured":"Ruxton, C. H. S., Reed, S. C., Simpson, M. J. A. & Millington, K. J. The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. J Hum Nutr Diet \n                           20, 275\u2013285 (2007).","journal-title":"J Hum Nutr Diet"},{"key":"9311_CR56","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3945\/jn.112.171322","volume":"143","author":"CM Depner","year":"2013","unstructured":"Depner, C. M., Philbrick, K. A. & Jump, D. B. Docosahexaenoic Acid Attenuates Hepatic Inflammation, Oxidative Stress, and Fibrosis without Decreasing Hepatosteatosis in a Ldlr(-\/-) Mouse Model of Western Diet-Induced Nonalcoholic Steatohepatitis. J Nutr \n                           143, 315\u2013323, doi:10.3945\/jn.112.171322 (2013).","journal-title":"J Nutr"},{"key":"9311_CR57","doi-asserted-by":"publisher","unstructured":"Furukawa, M., Gohda, T., Tanimoto, M. & Tomino, Y. Pathogenesis and Novel Treatment from the Mouse Model of Type 2 Diabetic Nephropathy. Sci World J, doi: 10.1155\/2013\/928197 (2013).","DOI":"10.1155\/2013\/928197"},{"key":"9311_CR58","doi-asserted-by":"publisher","unstructured":"Zhang, Z. H. et al. An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure. Sci Rep-Uk \n                           6, doi:10.1038\/Srep22151 (2016).","DOI":"10.1038\/Srep22151"},{"key":"9311_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059617","volume":"8","author":"YY Zhao","year":"2013","unstructured":"Zhao, Y. Y. et al. Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism. Plos One \n                           8, e59617, doi:10.1371\/journal.pone.0059617 (2013).","journal-title":"Plos One"},{"key":"9311_CR60","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3109\/1354750X.2011.637180","volume":"17","author":"YY Zhao","year":"2012","unstructured":"Zhao, Y. Y. et al. Serum metabonomics study of adenine-induced chronic renal failure in rats by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals \n                           17, 48\u201355, doi:10.3109\/1354750X.2011.637180 (2012).","journal-title":"Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals"},{"key":"9311_CR61","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.cca.2012.06.005","volume":"413","author":"YY Zhao","year":"2012","unstructured":"Zhao, Y. Y. et al. Effect of ergosta-4, 6, 8(14), 22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: a serum metabonomic study based on ultra performance liquid chromatography\/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm. Clin Chim Acta \n                           413, 1438\u20131445, doi:10.1016\/j.cca.2012.06.005 (2012).","journal-title":"Clin Chim Acta"},{"key":"9311_CR62","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1513\/pats.201201-005AW","volume":"9","author":"BS Shea","year":"2012","unstructured":"Shea, B. S. & Tager, A. M. Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis. Proceedings of the American Thoracic Society \n                           9, 102\u2013110, doi:10.1513\/pats.201201-005AW (2012).","journal-title":". Proceedings of the American Thoracic Society"},{"key":"9311_CR63","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.redox.2016.09.014","volume":"10","author":"H Chen","year":"2016","unstructured":"Chen, H. et al. Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression. Redox Biol \n                           10, 168\u2013178, doi:10.1016\/j.redox.2016.09.014 (2016).","journal-title":"Redox Biol"},{"key":"9311_CR64","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1161\/01.ATV.21.6.937","volume":"21","author":"K Yasunari","year":"2001","unstructured":"Yasunari, K., Maeda, K., Minami, M. & Yoshikawa, J. HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress. Arterioscl Throm Vas \n                           21, 937\u2013942 (2001).","journal-title":"Arterioscl Throm Vas"},{"key":"9311_CR65","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/(SICI)1521-3803(19990601)43:3<175::AID-FOOD175>3.0.CO;2-Z","volume":"43","author":"M Silano","year":"1999","unstructured":"Silano, M. & De Vincenzi, M. Bioactive antinutritional peptides derived from cereal prolamins: A Review. Nahrung \n                           43, 175\u2013184, doi:10.1002\/(Sici)1521-3803(19990601)43:3<175::Aid-Food175>3.0.Co;2-Z (1999).","journal-title":"Nahrung"},{"key":"9311_CR66","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1136\/gut.2004.053728","volume":"54","author":"T Itagaki","year":"2005","unstructured":"Itagaki, T. et al. Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells. Gut \n                           54, 1782\u20131789, doi:10.1136\/gut.2005.053278 (2005).","journal-title":"Gut"},{"key":"9311_CR67","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/gut.44.1.127","volume":"44","author":"I Shimizu","year":"1999","unstructured":"Shimizu, I. et al. Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro. Gut \n                           44, 127\u2013136 (1999).","journal-title":"Gut"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09311-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09311-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09311-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T08:59:40Z","timestamp":1671785980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09311-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,18]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["9311"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-09311-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,18]]},"assertion":[{"value":"17 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8830"}}